Robert Wynn
About
Robert Wynn is a scholar working on Physiology, Hematology and Epidemiology.
According to data from OpenAlex, Robert Wynn has authored 300 papers receiving a total of 7.9k indexed citations (citations by other indexed papers that have themselves been cited), including 92 papers in Physiology, 84 papers in Hematology and 44 papers in Epidemiology. Recurrent topics in Robert Wynn's work include Lysosomal Storage Disorders Research (63 papers), Hematopoietic Stem Cell Transplantation (49 papers) and Acute Lymphoblastic Leukemia research (23 papers). Robert Wynn is often cited by papers focused on Lysosomal Storage Disorders Research (63 papers), Hematopoietic Stem Cell Transplantation (49 papers) and Acute Lymphoblastic Leukemia research (23 papers). Robert Wynn collaborates with scholars based in United Kingdom, United States and Netherlands. Robert Wynn's co-authors include J. E. Wraith, Ilaria Bellantuono, Leslie J. Fairbairn, Brian Bigger, Simon Jones, Jaap Jan Boelens, M. Baxter, Simon N. Jowitt, Paul Veys and Kia Langford‐Smith and has published in prestigious journals such as Nature, The Lancet and Journal of Biological Chemistry.
In The Last Decade
Robert Wynn
287 papers receiving 7.7k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Robert Wynn United Kingdom | 45 | 2.7k | 1.8k | 1.7k | 1.5k | 1.5k | 300 | 7.9k | ||
| Carlo Salvarani Italy | 77 | 2.7k 1.0× | 4.5k 2.5× | 2.3k 1.4× | 2.0k 1.3× | 1.6k 1.1× | 598 | 24.3k | ||
| Roberto Giacomelli Italy | 54 | 1.2k 0.5× | 649 0.4× | 2.1k 1.2× | 1.8k 1.2× | 787 0.5× | 304 | 9.3k | ||
| Paul Harmatz United States | 53 | 5.4k 2.0× | 2.3k 1.3× | 1.4k 0.8× | 2.1k 1.3× | 2.7k 1.9× | 310 | 9.8k | ||
| Guido Valesini Italy | 64 | 2.2k 0.8× | 545 0.3× | 2.3k 1.4× | 2.7k 1.7× | 1.6k 1.1× | 561 | 16.3k | ||
| William P. Arend United States | 58 | 3.0k 1.1× | 1.5k 0.9× | 4.4k 2.6× | 1.6k 1.0× | 1.8k 1.2× | 139 | 22.1k | ||
| Sung‐Hwan Park South Korea | 59 | 1.3k 0.5× | 601 0.3× | 3.7k 2.2× | 916 0.6× | 1.1k 0.7× | 479 | 13.2k | ||
| Holger Jon Møller Denmark | 57 | 1.6k 0.6× | 421 0.2× | 2.4k 1.4× | 651 0.4× | 3.2k 2.2× | 273 | 11.1k | ||
| Romain K. Gherardi France | 55 | 1.3k 0.5× | 1.3k 0.8× | 4.2k 2.5× | 400 0.3× | 2.3k 1.6× | 247 | 11.2k | ||
| Paula K. Roberson United States | 51 | 970 0.4× | 625 0.4× | 5.1k 3.0× | 2.2k 1.5× | 1.2k 0.8× | 123 | 12.1k | ||
| Gwan Gyu Song South Korea | 44 | 639 0.2× | 516 0.3× | 1.8k 1.0× | 889 0.6× | 954 0.7× | 457 | 9.1k |
Countries citing papers authored by Robert Wynn
Since
Specialization
Citations
This map shows the geographic impact of Robert Wynn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Wynn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Wynn more than expected).
Fields of papers citing papers by Robert Wynn
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Robert Wynn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Wynn. The network helps show where Robert Wynn may publish in the future.
Co-authorship network of co-authors of Robert Wynn
This figure shows the co-authorship network connecting the top 25 collaborators of Robert Wynn. A scholar is included among the top collaborators of Robert Wynn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Wynn. Robert Wynn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Sharma, Reena, Simon Jones, Robert Wynn, et al.. (2025). Iron metabolism and hematological abnormalities in adult patients affected with mucopolysaccharidoses. Molecular Genetics and Metabolism Reports. 44. 101243–101243.
2.
Donald, Aimée, et al.. (2025). Gene therapy in neuronopathic lysosomal storage disorders. European Journal of Paediatric Neurology. 57. 41–49.
3.
Nademi, Zohreh, Alexandra Laberko, Dmitry Balashov, et al.. (2025). Outcomes of Hematopoietic Stem Cell Transplantation in 5 Patients with Autosomal Recessive RIPK1-Deficiency. Journal of Clinical Immunology. 45(1). 65–65.
4.
White, F., Jane Roberts, James A. Cooper, et al.. (2025). Does Early Diagnosis and Treatment Alter the Clinical Course of Wolman Disease? Divergent Trajectories in Two Siblings and a Consideration for Newborn Screening. International Journal of Neonatal Screening. 11(1). 17–17.
5.
Altmann, Thomas, Kanchan Rao, Katharine Patrick, et al.. (2025). Low rates of endothelial cell dysfunction and transplant‐related mortality in 537 children receiving fludarabine–treosulfan conditioning for all transplant indications: A retrospective multicentre study on behalf of the UK Paediatric BMT group. British Journal of Haematology. 207(2). 631–635.
6.
Marón, Gabriela, Allistair Abraham, Alice Bertaina, et al.. (2024). Strategic infection prevention after genetically modified hematopoietic stem cell therapies: recommendations from the International Society for Cell & Gene Therapy Stem Cell Engineering Committee. Cytotherapy. 26(7). 660–671.
7.
Anderson, Nathaniel D., Ignacio Criado, Eleonora Khabirova, et al.. (2023). Transcriptional signatures associated with persisting CD19 CAR-T cells in children with leukemia. Nature Medicine. 29(7). 1700–1709.
8.
Klein, Orly R., Carmem Bonfim, Allistair Abraham, et al.. (2023). Transplant for non-malignant disorders: an International Society for Cell & Gene Therapy Stem Cell Engineering Committee report on the role of alternative donors, stem cell sources and graft engineering. Cytotherapy. 25(5). 463–471.
9.
Abraham, Allistair, Alice Bertaina, Senthil Velan Bhoopalan, et al.. (2023). International Society for Cell & Gene Therapy Stem Cell Engineering Committee: Cellular therapies for the treatment of graft-versus-host-disease after hematopoietic stem cell transplant. Cytotherapy. 25(6). 578–589.
10.
Stanojević, Maja, Alice Bertaina, Carmem Bonfim, et al.. (2022). Viral infection in hematopoietic stem cell transplantation: an International Society for Cell & Gene Therapy Stem Cell Engineering Committee review on the role of cellular therapy in prevention and treatment. Cytotherapy. 24(9). 884–891.
11.
Mohty, Mohamad, Marta Lisa Battista, Didier Blaise, et al.. (2021). A multicentre, multinational, prospective, observational registry study of defibrotide in patients diagnosed with veno-occlusive disease/sinusoidal obstruction syndrome after haematopoietic cell transplantation: an EBMT study. Bone Marrow Transplantation. 56(10). 2454–2463.
12.
Lucchini, Giovanna, Caroline L. Furness, Sarah Lawson, et al.. (2021). COVID‐19 infection in paediatric recipients of allogeneic stem cell transplantation: the UK experience. British Journal of Haematology. 194(4). e74–e77.
13.
Leonard, Alexis, Alice Bertaina, Carmem Bonfim, et al.. (2021). Curative therapy for hemoglobinopathies: an International Society for Cell & Gene Therapy Stem Cell Engineering Committee review comparing outcomes, accessibility and cost of ex vivo stem cell gene therapy versus allogeneic hematopoietic stem cell transplantation. Cytotherapy. 24(3). 249–261.
14.
Davies, Emma, Andrew Turner, Malcolm Guiver, et al.. (2020). Burden of adenoviraemia predicts survival in paediatric recipients of allogeneic haematopoietic stem cell transplant. Journal of Clinical Virology. 127. 104373–104373.
15.
Kerr, Deborah A., et al.. (2017). SIFD as a novel cause of severe fetal hydrops and neonatal anaemia with iron loading and marked extramedullary haemopoiesis. Journal of Clinical Pathology. 71(3). 275–278.
16.
Langford-Smith, Alex, Claire E. Pickford, John McDermott, et al.. (2013). Myeloid/Microglial Driven Autologous Hematopoietic Stem Cell Gene Therapy Corrects a Neuronopathic Lysosomal Disease. Molecular Therapy. 21(10). 1938–1949.
17.
Wynn, Robert. (2003). The top 50 prescription medications dispensed in pharmacies in 2001.. PubMed. 50(5). 400–4, 406.
18.
Wynn, Robert. (2001). The new COX-2 inhibitors: rofecoxib (Vioxx) and celecoxib (Celebrex).. PubMed. 48(1). 16–20.
19.
Robertson, Jane & Robert Wynn. (2000). Telomerase Activity and Telomere Length in the Haemopoietic System: Changes with Aging, Disease, and Therapy. 3(4). 389–395.
20.
Lao, Lixing, et al.. (1995). Electroacupuncture Reduces Morphine-Induced Emesis in Ferrets: A Pilot Study. The Journal of Alternative and Complementary Medicine. 1(3). 257–261.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Carlo Salvarani Breakdown of academic impact, for papers by Roberto Giacomelli Breakdown of academic impact, for papers by Paul Harmatz Breakdown of academic impact, for papers by Guido Valesini Breakdown of academic impact, for papers by William P. Arend Breakdown of academic impact, for papers by Sung‐Hwan Park Breakdown of academic impact, for papers by Holger Jon Møller Breakdown of academic impact, for papers by Romain K. Gherardi Breakdown of academic impact, for papers by Paula K. Roberson Breakdown of academic impact, for papers by Gwan Gyu Song